<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35669940</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1432-9123</ISSN><JournalIssue CitedMedium="Print"><Volume>26</Volume><Issue>2</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Somnologie : Schlafforschung und Schlafmedizin = Somnology : sleep research and sleep medicine</Title><ISOAbbreviation>Somnologie (Berl)</ISOAbbreviation></Journal><ArticleTitle>[Sleep disorders and fatigue syndrome in long COVID syndrome: case-based experiences from neurological/sleep medicine rehabilitation].</ArticleTitle><Pagination><StartPage>73</StartPage><EndPage>79</EndPage><MedlinePgn>73-79</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11818-022-00353-9</ELocationID><Abstract><AbstractText>Sleep disturbances and clinically significant fatigue syndrome are regularly described for long COVID syndrome. The pathophysiological correlations remain unknown. The clinical presentation is variable and must be considered individually. Four case studies will be used to illustrate the symptoms that constitute long COVID syndrome and the treatment options available. Multimodal individualized rehabilitation seems to be suitable to return those affected to their premorbid performance and to achieve a&#xa0;considerable reduction in insomniac complaints.</AbstractText><CopyrightInformation>&#xa9; The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Young</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Reithofpark, Klinik f&#xfc;r Neurologie, Medicalpark Bad Feilnbach, 83075 Bad Feilnbach, Deutschland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Schlafst&#xf6;rungen und Ersch&#xf6;pfungssyndrom bei Long-COVID-Syndrom: Fallbasierte Erfahrungen aus der neurologischen/schlafmedizinischen Rehabilitation.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Somnologie (Berl)</MedlineTA><NlmUniqueID>9809663</NlmUniqueID><ISSNLinking>1432-9123</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="Publisher" Language="ger"><AbstractText>Schlafst&#xf6;rungen und ein klinisch signifikantes Ersch&#xf6;pfungssyndrom werden f&#xfc;r das Long-COVID-Syndrom regelhaft beschrieben. Die pathophysiologischen Zusammenh&#xe4;nge sind weitergehend unbekannt. Die klinische Pr&#xe4;sentation ist unterschiedlich und muss individuell betrachtet werden. Anhand von vier Fallbeispielen wird dargestellt, welche Symptome ein Long-COVID-Syndrom ausmachen und welche Therapieoptionen zur Verf&#xfc;gung stehen. Eine multimodale individualisierte Rehabilitation scheint geeignet, Betroffene wieder an die pr&#xe4;morbide Leistungsf&#xe4;higkeit heranzuf&#xfc;hren und eine erhebliche Reduktion von insomnischen Beschwerden zu erreichen.</AbstractText><CopyrightInformation>&#xa9; The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2022.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID</Keyword><Keyword MajorTopicYN="N">Rehabilitation</Keyword><Keyword MajorTopicYN="N">Sars-CoV2</Keyword><Keyword MajorTopicYN="N">Sleep disorders</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>7</Day><Hour>2</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35669940</ArticleId><ArticleId IdType="pmc">PMC9149331</ArticleId><ArticleId IdType="doi">10.1007/s11818-022-00353-9</ArticleId><ArticleId IdType="pii">353</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. J Infect Dis. 2021 doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, et al. Symptoms, complications and management of long COVID: a&#xa0;review. J R Soc Med. 2021 doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a&#xa0;systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020 doi: 10.1016/S2215-0366(20)30203-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Stussman B, Williams A, Snow J, et al. Characterization of post&#x2013;exertional malaise in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Front Neurol. 2020 doi: 10.3389/fneur.2020.01025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.01025</ArticleId><ArticleId IdType="pmc">PMC7530890</ArticleId><ArticleId IdType="pubmed">33071931</ArticleId></ArticleIdList></Reference><Reference><Citation>May M, Milrad SF, Perdomo DM, et al. Post-exertional malaise is associated with greater symptom burden and psychological distress in patients diagnosed with Chronic Fatigue Syndrome. J Psychosom Res. 2020 doi: 10.1016/j.jpsychores.2019.109893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2019.109893</ArticleId><ArticleId IdType="pmc">PMC7007968</ArticleId><ArticleId IdType="pubmed">31884303</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S, Abdallah SJ, Corrales-Medina V, Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a&#xa0;narrative review. Therapeutic Advances in Infection. 2021 doi: 10.1177/20499361211009385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211009385</ArticleId><ArticleId IdType="pmc">PMC8060761</ArticleId><ArticleId IdType="pubmed">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Shikova E, Reshkova V, Kumanova &#x410;, et al. Cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic &#x435;ncephalomyelitis/chronic fatigue syndrome. J Med Virol. 2020 doi: 10.1002/jmv.25744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25744</ArticleId><ArticleId IdType="pmc">PMC7687071</ArticleId><ArticleId IdType="pubmed">32129496</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C. Long COVID: current definition. Infection. 2022 doi: 10.1007/s15010-021-01696-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01696-5</ArticleId><ArticleId IdType="pmc">PMC8438555</ArticleId><ArticleId IdType="pubmed">34519974</ArticleId></ArticleIdList></Reference><Reference><Citation>v. Raveendran A, Jayadevan R, Sashidharan S. Long COVID: An overview. Diabetes Metab Syndr. 2021 doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla AR, Ankermann T, Behrends U, et al. S1 guideline post-COVID/long-COVID. Pneumologie. 2021 doi: 10.1055/a-1551-9734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1551-9734</ArticleId><ArticleId IdType="pubmed">34474488</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Akbari A, Emami A, et al. Long COVID syndrome-associated brain fog. J Med Virol. 2021 doi: 10.1002/jmv.27404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27404</ArticleId><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, Freitag H, Meyer-Arndt L, et al. Chronic COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) following the first pandemic wave in Germany&#x2014;A&#xa0;first analysis of a&#xa0;prospective observational study. 2021.</Citation></Reference><Reference><Citation>Kyzar EJ, Purpura LJ, Shah J, Cantos A, Nordvig AS, Yin MT. Anxiety, depression, insomnia, and trauma-related symptoms following COVID-19 infection at long-term follow-up. Brain Behav Immun Health. 2021 doi: 10.1016/j.bbih.2021.100315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100315</ArticleId><ArticleId IdType="pmc">PMC8321961</ArticleId><ArticleId IdType="pubmed">34345869</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocevska D, Blanken TF, van Someren EJW, R&#xf6;sler L. Sleep quality during the COVID-19 pandemic: not one size fits all. Sleep Med. 2020 doi: 10.1016/j.sleep.2020.09.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sleep.2020.09.029</ArticleId><ArticleId IdType="pmc">PMC7543757</ArticleId><ArticleId IdType="pubmed">33126035</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, et al. Persistent symptoms in adult patients 1 year after Coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis. 2021 doi: 10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter K, Kellner S. &#x201c;Coronasomnia&#x201d;&#x2014;promoting resilience through insomnia treatment. Somnologie. 2021 doi: 10.1007/s11818-021-00322-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11818-021-00322-8</ArticleId><ArticleId IdType="pmc">PMC8381348</ArticleId><ArticleId IdType="pubmed">34456621</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Alawi M, McCall RK, Sultan A, et al. Efficacy of a&#xa0;six-week-long therapist-guided online therapy versus self-help internet-based therapy for COVID-19&#x2013;induced anxiety and depression: Open-label, pragmatic, randomized controlled trial. JMIR Ment Health. 2021 doi: 10.2196/26683.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/26683</ArticleId><ArticleId IdType="pmc">PMC7886373</ArticleId><ArticleId IdType="pubmed">33512323</ArticleId></ArticleIdList></Reference><Reference><Citation>Hospital KU (2021) Safety and efficacy of hyperbaric oxygen therapy for long COVID syndrome. ClinicalTrials.gov. Zugegriffen: 31.01.2022</Citation></Reference><Reference><Citation>Deer RR, Rock MA, Vasilevsky N, et al. Characterizing long COVID: deep phenotype of a&#xa0;complex condition. EBioMedicine. 2021 doi: 10.1016/j.ebiom.2021.103722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Akbari A, Emami A, et al. Risk factors associated with long covid syndrome: A retrospective study. Iran J Med Sci. 2021 doi: 10.30476/ijms.2021.92080.2326.</Citation><ArticleIdList><ArticleId IdType="doi">10.30476/ijms.2021.92080.2326</ArticleId><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva RN, Goulart CDL, Oliveira MR, et al. Cardiorespiratory and skeletal muscle damage due to COVID-19: making the urgent case for rehabilitation. Expert Rev Respir Med. 2021 doi: 10.1080/17476348.2021.1893169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17476348.2021.1893169</ArticleId><ArticleId IdType="pubmed">33606567</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagnato S, Boccagni C, Marino G, Prestandrea C, D&#x2019;Agostino T, Rubino F. Critical illness myopathy after COVID-19. Int J Infect Dis. 2020 doi: 10.1016/j.ijid.2020.07.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.07.072</ArticleId><ArticleId IdType="pmc">PMC7403134</ArticleId><ArticleId IdType="pubmed">32763444</ArticleId></ArticleIdList></Reference><Reference><Citation>Medrinal C, Prieur G, Bonnevie T, et al. Muscle weakness, functional capacities and recovery for COVID-19 ICU survivors. BMC Anesthesiol. 2021 doi: 10.1186/s12871-021-01274-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-021-01274-0</ArticleId><ArticleId IdType="pmc">PMC7921277</ArticleId><ArticleId IdType="pubmed">33653264</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesquisa AF de I a (2020) Melatonin agonist on hospitalized patients with confirmed or suspected COVID-19. ClinicalTrials.gov. Zugegriffen: 31.01.2022</Citation></Reference><Reference><Citation>Ramos E, L&#xf3;pez-Mu&#xf1;oz F, Gil-Mart&#xed;n E, et al. The coronavirus disease 2019 (Covid-19): key emphasis on melatonin safety and therapeutic efficacy. Antioxidants. 2021 doi: 10.3390/antiox10071152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10071152</ArticleId><ArticleId IdType="pmc">PMC8301107</ArticleId><ArticleId IdType="pubmed">34356384</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan DX, Hardeland R. Estimated doses of melatonin for treating deadly virus infections: focus on COVID-19. Melatonin Res. 2020 doi: 10.32794/mr11250062.</Citation><ArticleIdList><ArticleId IdType="doi">10.32794/mr11250062</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Gao L, Tong X, et al. Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: a&#xa0;descriptive cohort study among 1.1&#xa0;million vaccinated people in Hong Kong. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9008125</ArticleId><ArticleId IdType="pubmed">35461018</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter K, Kellner S, Hillemacher T, Golubnitschaja O. Sleep quality and COVID-19 outcomes: the evidence-based lessons in the framework of predictive, preventive and personalised (3P) medicine. Epma J. 2021 doi: 10.1007/s13167-021-00245-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13167-021-00245-2</ArticleId><ArticleId IdType="pmc">PMC8185312</ArticleId><ArticleId IdType="pubmed">34122671</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain K, Jiandani M, Lohakare P. Physiotherapy rehabilitation in long COVID: a case series. Int J Sci Res. 2020 doi: 10.36106/ijsr/6303156.</Citation><ArticleIdList><ArticleId IdType="doi">10.36106/ijsr/6303156</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Saugar M, Ja&#xe9;n-Jover C, Hern&#xe1;ndez-S&#xe1;nchez S, Poveda-Pag&#xe1;n EJ, Lozano-Quijada C. Recommendations for outpatient respiratory rehabilitation of long COVID patients. An Sist Sanit Navar. 2021 doi: 10.23938/assn.0978.</Citation><ArticleIdList><ArticleId IdType="doi">10.23938/assn.0978</ArticleId><ArticleId IdType="pmc">PMC10114010</ArticleId><ArticleId IdType="pubmed">34750595</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabady S, Altenberger J, Brose M, et al. Guideline S1: Long COVID: Diagnostics and treatment strategies. Wien Klin Wochenschr. 2021 doi: 10.1007/s00508-021-01974-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-021-01974-0</ArticleId><ArticleId IdType="pmc">PMC8633909</ArticleId><ArticleId IdType="pubmed">34851455</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>